1042 / 1241
Safety/Toxicity/Dosage
Phase I
Therapy effectiveness
Safety
Randomisation
Tested vs standard
treatment
Phase II
Phase III
Go/No go
Go/No go
Question: Is the therapy
safe & is there biological
activity?
Question: Does the
therapy work sufficiently
well?
Question: How well does
the therapy compare to
what we have?
Clinical Trials:
Response criteria